Shree Organo Chemicals (Ahd) Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 07-12-2024
- Paid Up Capital ₹ 6.37 M
as on 07-12-2024
- Company Age 31 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.30 Cr
as on 07-12-2024
- Revenue 154.99%
(FY 2022)
- Profit 87.56%
(FY 2022)
- Ebitda 147.16%
(FY 2022)
- Net Worth 51.41%
(FY 2022)
- Total Assets -0.35%
(FY 2022)
About Shree Organo Chemicals (Ahd)
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.37 M.
The company has closed loans amounting to ₹1.30 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mayur Jani and Sanjay Trivedi serve as directors at the Company.
- CIN/LLPIN
U24117GJ1994PTC021099
- Company No.
021099
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Organo Chemicals (Ahd)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Trivedi  | Director | 01-Apr-2014 | Current |
| Mayur Jani | Director | 01-Apr-2014 | Current |
Financial Performance of Shree Organo Chemicals (Ahd).
Shree Organo Chemicals (Ahd) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 154.99% increase. The company also saw a substantial improvement in profitability, with a 87.56% increase in profit. The company's net worth Soared by an impressive increase of 51.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Organo Chemicals (Ahd)?
In 2020, Shree Organo Chemicals (Ahd) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Charges (Loans)
₹0
₹12.97 M
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.72 Cr
- Gujarat State Financial Corporation : 0.58 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2002 | Indian Overseas Bank | ₹0.90 M | Satisfied |
| 03 Feb 1995 | Gujarat State Financial Corporation | ₹5.77 M | Satisfied |
| 18 Oct 1994 | Indian Overseas Bank | ₹6.30 M | Satisfied |
How Many Employees Work at Shree Organo Chemicals (Ahd)?
Unlock and access historical data on people associated with Shree Organo Chemicals (Ahd), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Organo Chemicals (Ahd), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Organo Chemicals (Ahd)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
